According to Pacific Biosciences 's latest financial reports the company's current EPS (TTM) is -$1.27. In 2022 the company made an earnings per share (EPS) of -$1.40 a decrease over its 2021 EPS that were of -$0.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.27 | -9.29% |
2022 | -$1.40 | 57.3% |
2021 | -$0.89 | -841.67% |
2020 | $0.12 | -121.79% |
2019 | -$0.55 | -28.49% |
2018 | -$0.77 | -13.48% |
2017 | -$0.89 | 7.23% |
2016 | -$0.83 | 93.02% |
2015 | -$0.43 | -54.26% |
2014 | -$0.94 | -25.98% |
2013 | -$1.27 | -25.29% |
2012 | -$1.70 | -16.26% |
2011 | -$2.03 | -98.56% |
2010 | -$140.56 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $15.34 | -1,307.87% | ๐บ๐ธ USA |
General Electric GE | $8.55 | -773.23% | ๐บ๐ธ USA |
Illumina ILMN | -$26.61 | 1,995.28% | ๐บ๐ธ USA |
PerkinElmer
PKI | $7.70 | -706.28% | ๐บ๐ธ USA |
NanoString Technologies NSTG | -$3.54 | 178.74% | ๐บ๐ธ USA |